Utility of FDG-PET/CT in the follow-up of neuroblastoma which became MIBG-negative

Pediatric Blood and Cancer

Volumn 52, Issue 4, 2009, Pages 552-

  Dowell, Heather Mc ^a   Losty, Paul ^a   Barnes, Nik ^a   Kokai, George ^a  

^a ALDER HEY CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE; CARBOPLATIN; ETOPOSIDE; FLUORODEOXYGLUCOSE; MELPHALAN; RETINOIC ACID; ANTINEOPLASTIC AGENT; DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

BRAIN SCINTISCANNING; BRAIN SURGERY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER STAGING; CASE REPORT; CHILD; CLINICAL FEATURE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DRUG MEGADOSE; FEMALE; FOLLOW UP; HUMAN; LETTER; NEUROBLASTOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; ADRENAL TUMOR; COMPUTER ASSISTED TOMOGRAPHY; ENDOCRINE SURGERY; INFANT; METHODOLOGY; MULTIMODALITY CANCER THERAPY; NOTE; POSITRON EMISSION TOMOGRAPHY; RADIOTHERAPY; SCINTISCANNING; TUMOR RECURRENCE;

3-IODOBENZYLGUANIDINE; ADRENAL GLAND NEOPLASMS; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; ENDOCRINE SURGICAL PROCEDURES; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; INFANT; NEOPLASM RECURRENCE, LOCAL; NEUROBLASTOMA; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RADIOTHERAPY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 65249140061     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21859     Document Type: Letter

References (5)

1. Colavolpe C, Guedj E, Cammilleri S, et al. Utility of FDG-PET/CT in the follow-up of neuroblastoma which became MIBG-negative. Pediatr Blood Cancer 2008;51:828-831.
2. Heyman S, Evans AE, D'Angio GJ. I-131 metaiodobenzylguani- dine: Diagnostic use in neuroblastoma patients in relapse. Med Pediatr Oncol 1988;16:337-340.
3. Englaro EE, Gelfand MJ, Harris RE, et al. I-131MIBG imaging after bone marrow transplantation for neuroblastoma. Radiology 1992; 182:515-520.
4. Reuland P, Geiger L, Thelen MH, et al. Follow-up in neuroblastoma: Comparison of metaiodobenzylguanidine and a chimeric anti-GD2 antibody for detection of tumor relapse and therapy response. J Pediatr Hematol Oncol 2001;23:437-442.
5. Kushner BH, Yeung HW, Larson SM, et al. Extending positron emission tomography scan utility to high-risk neuroblastoma: Fluorine-18 fluorodeoxyglucose positron emission tomography as sole imaging modality in follow-up of patients. J Clin Oncol 2001; 19:3397-3405.